Published in PLoS Pathog on September 08, 2016
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. J Mol Biol (1984) 8.87
Structural features of the herpes simplex virus alpha gene 4, 0, and 27 promoter-regulatory sequences which confer alpha regulation on chimeric thymidine kinase genes. J Virol (1982) 7.35
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature (2008) 5.29
Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation. Cell (1988) 5.18
A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence. Cell (1988) 4.68
Herpes simplex virus latency-associated transcript is a stable intron. Proc Natl Acad Sci U S A (1991) 3.87
Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins. Proc Natl Acad Sci U S A (1987) 3.87
Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol (1989) 3.63
Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J Virol (1992) 3.56
The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J Virol (1993) 3.43
ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays (2000) 3.09
Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J Virol (1992) 2.90
Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus 1 alpha genes. Proc Natl Acad Sci U S A (1987) 2.90
The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem Sci (2003) 2.85
The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol (1997) 2.55
Comprehensive quantification of herpes simplex virus latency at the single-cell level. J Virol (1997) 2.51
Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med (2009) 2.51
The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 2.50
Physical location of a herpes simplex virus type-1 gene function(s) specifically associated with a 10 million-fold increase in HSV neurovirulence. Virology (1983) 2.19
Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol (2001) 2.17
Analysis of DNA sequences which regulate the transcription of herpes simplex virus immediate early gene 3: DNA sequences required for enhancer-like activity and response to trans-activation by a virion polypeptide. Nucleic Acids Res (1986) 2.08
Mutational analysis of the herpes simplex virus type 1 trans-inducing factor Vmw65. J Gen Virol (1988) 2.06
Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol (1990) 2.03
Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol (1993) 2.01
Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. J Virol (1990) 1.85
The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J Virol (1998) 1.84
Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology (1992) 1.81
Regulation of alphaherpesvirus infections by the ICP0 family of proteins. J Gen Virol (2012) 1.76
ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol (2001) 1.76
Transport and egress of herpes simplex virus in neurons. Rev Med Virol (2008) 1.72
Herpes simplex virus neurovirulence and productive infection of neural cells is associated with a function which maps between 0.82 and 0.832 map units on the HSV genome. Virology (1989) 1.68
Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc Natl Acad Sci U S A (1999) 1.64
HCF-dependent nuclear import of VP16. EMBO J (1999) 1.56
De novo synthesis of VP16 coordinates the exit from HSV latency in vivo. PLoS Pathog (2009) 1.56
Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J Virol (1998) 1.52
Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes. J Virol (2009) 1.48
Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment. J Virol (1985) 1.45
Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis. J Virol (2009) 1.44
Control of expression of the varicella-zoster virus major immediate early gene. J Gen Virol (1990) 1.43
Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence. J Virol (1987) 1.40
Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65. J Gen Virol (1992) 1.40
Herpesvirus transport to the nervous system and back again. Annu Rev Microbiol (2012) 1.40
DNA sequences which regulate the expression of the pseudorabies virus major immediate early gene. Virology (1987) 1.37
Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1. J Virol (2000) 1.36
Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice. J Virol (1991) 1.31
Truncation of the C-terminal acidic transcriptional activation domain of herpes simplex virus VP16 produces a phenotype similar to that of the in1814 linker insertion mutation. J Virol (1997) 1.28
Protein interactions in the herpes simplex virus type 1 VP16-induced complex: VP16 peptide inhibition and mutational analysis of host cell factor requirements. J Virol (1997) 1.27
Reactivation in vivo and in vitro of herpes simplex virus from mouse dorsal root ganglia which contain different levels of latency-associated transcripts. J Gen Virol (1993) 1.26
Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA. Mol Cell Biol (1997) 1.26
A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II. EMBO J (1997) 1.25
Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo. J Virol (2006) 1.24
Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences. J Virol (2004) 1.24
The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection. Virology (1994) 1.23
Investigation of herpes simplex virus type 1 (HSV-1) gene expression and DNA synthesis during the establishment of latent infection by an HSV-1 mutant, in1814, that does not replicate in mouse trigeminal ganglia. J Gen Virol (1991) 1.21
Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation. J Virol (2003) 1.20
Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814. J Gen Virol (1991) 1.20
Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system. J Virol (1997) 1.19
Synchronous appearance of antigen-positive and latently infected neurons in spinal ganglia of mice infected with a virulent strain of herpes simplex virus. J Gen Virol (1992) 1.19
Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture. J Virol (2013) 1.19
Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo. J Virol (2003) 1.15
A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency. Cell Host Microbe (2014) 1.11
The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems. Virology (1999) 1.10
Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J Virol (1994) 1.08
Activities of ICP0 involved in the reversal of silencing of quiescent herpes simplex virus 1. J Virol (2011) 1.05
Transient reversal of episome silencing precedes VP16-dependent transcription during reactivation of latent HSV-1 in neurons. PLoS Pathog (2012) 1.04
Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains. Virology (2000) 1.03
Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog (2012) 1.02
A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones. J Gen Virol (2008) 1.01
Herpes simplex virus infections are arrested in Oct-1-deficient cells. Proc Natl Acad Sci U S A (2004) 1.01
Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia. Virology (2011) 1.01
The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice. J Neurovirol (2003) 0.98
HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity. Cells (2014) 0.96
An analysis of herpes simplex virus gene expression during latency establishment and reactivation. J Gen Virol (1999) 0.95
The octamer binding protein Oct-2 inhibits transactivation of the herpes simplex virus immediate-early genes by the virion protein Vmw65. Virology (1993) 0.95
A network of protein interactions around the herpes simplex virus tegument protein VP22. J Virol (2012) 0.95
Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. Virology (1998) 0.94
Ultrastructural visualization of individual tegument protein dissociation during entry of herpes simplex virus 1 into human and rat dorsal root ganglion neurons. J Virol (2012) 0.89
An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones. J Gen Virol (2011) 0.89
The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections. J Neurovirol (2011) 0.87
Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection. J Virol (2013) 0.86
Two patterns of persistence of herpes simplex virus DNA sequences in the nervous systems of latently infected mice. J Gen Virol (1992) 0.86
Reactivation from quiescence does not coincide with a global induction of herpes simplex virus type 1 transactivators. Virus Genes (2006) 0.85
The exchange of cognate TATA boxes results in a corresponding change in the strength of two HSV-1 early promoters. Virus Genes (2000) 0.84
DNA sequence and RNA transcription through a site of recombination in a non-neurovirulent herpes simplex virus intertypic recombinant. Virus Genes (1988) 0.83
Two leaky-late HSV-1 promoters differ significantly in structural architecture. Virology (2000) 0.83
Infected cell protein 0 functional domains and their coordination in herpes simplex virus replication. World J Virol (2016) 0.79
VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo. J Neurovirol (2011) 0.79
One-dimensional SDS gel electrophoresis of proteins. Curr Protoc Mol Biol (2012) 0.78